Cargando…
Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation
Systemic sclerosis (SSc; scleroderma) is a multisystem fibrotic disease. The mammalian cleavage factor I 25-kD subunit (CFIm25; encoded by NUDT21) is a key regulator of alternative polyadenylation, and its depletion causes predominantly 3′UTR shortening through loss of stimulation of distal polyaden...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041714/ https://www.ncbi.nlm.nih.gov/pubmed/31757866 http://dx.doi.org/10.1084/jem.20181384 |
_version_ | 1783501193498066944 |
---|---|
author | Weng, Tingting Huang, Jingjing Wagner, Eric J. Ko, Junsuk Wu, Minghua Wareing, Nancy E. Xiang, Yu Chen, Ning-Yuan Ji, Ping Molina, Jose G. Volcik, Kelly A. Han, Leng Mayes, Maureen D. Blackburn, Michael R. Assassi, Shervin |
author_facet | Weng, Tingting Huang, Jingjing Wagner, Eric J. Ko, Junsuk Wu, Minghua Wareing, Nancy E. Xiang, Yu Chen, Ning-Yuan Ji, Ping Molina, Jose G. Volcik, Kelly A. Han, Leng Mayes, Maureen D. Blackburn, Michael R. Assassi, Shervin |
author_sort | Weng, Tingting |
collection | PubMed |
description | Systemic sclerosis (SSc; scleroderma) is a multisystem fibrotic disease. The mammalian cleavage factor I 25-kD subunit (CFIm25; encoded by NUDT21) is a key regulator of alternative polyadenylation, and its depletion causes predominantly 3′UTR shortening through loss of stimulation of distal polyadenylation sites. A shortened 3′UTR will often lack microRNA target sites, resulting in increased mRNA translation due to evasion of microRNA-mediated repression. Herein, we report that CFlm25 is downregulated in SSc skin, primary dermal fibroblasts, and two murine models of dermal fibrosis. Knockdown of CFIm25 in normal skin fibroblasts is sufficient to promote the 3′UTR shortening of key TGFβ-regulated fibrotic genes and enhance their protein expression. Moreover, several of these fibrotic transcripts show 3′UTR shortening in SSc skin. Finally, mice with CFIm25 deletion in fibroblasts show exaggerated skin fibrosis upon bleomycin treatment, and CFIm25 restoration attenuates bleomycin-induced skin fibrosis. Overall, our data link this novel RNA-processing mechanism to dermal fibrosis and SSc pathogenesis. |
format | Online Article Text |
id | pubmed-7041714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-70417142020-08-03 Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation Weng, Tingting Huang, Jingjing Wagner, Eric J. Ko, Junsuk Wu, Minghua Wareing, Nancy E. Xiang, Yu Chen, Ning-Yuan Ji, Ping Molina, Jose G. Volcik, Kelly A. Han, Leng Mayes, Maureen D. Blackburn, Michael R. Assassi, Shervin J Exp Med Research Articles Systemic sclerosis (SSc; scleroderma) is a multisystem fibrotic disease. The mammalian cleavage factor I 25-kD subunit (CFIm25; encoded by NUDT21) is a key regulator of alternative polyadenylation, and its depletion causes predominantly 3′UTR shortening through loss of stimulation of distal polyadenylation sites. A shortened 3′UTR will often lack microRNA target sites, resulting in increased mRNA translation due to evasion of microRNA-mediated repression. Herein, we report that CFlm25 is downregulated in SSc skin, primary dermal fibroblasts, and two murine models of dermal fibrosis. Knockdown of CFIm25 in normal skin fibroblasts is sufficient to promote the 3′UTR shortening of key TGFβ-regulated fibrotic genes and enhance their protein expression. Moreover, several of these fibrotic transcripts show 3′UTR shortening in SSc skin. Finally, mice with CFIm25 deletion in fibroblasts show exaggerated skin fibrosis upon bleomycin treatment, and CFIm25 restoration attenuates bleomycin-induced skin fibrosis. Overall, our data link this novel RNA-processing mechanism to dermal fibrosis and SSc pathogenesis. Rockefeller University Press 2019-11-22 /pmc/articles/PMC7041714/ /pubmed/31757866 http://dx.doi.org/10.1084/jem.20181384 Text en © 2019 Weng et al. http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Research Articles Weng, Tingting Huang, Jingjing Wagner, Eric J. Ko, Junsuk Wu, Minghua Wareing, Nancy E. Xiang, Yu Chen, Ning-Yuan Ji, Ping Molina, Jose G. Volcik, Kelly A. Han, Leng Mayes, Maureen D. Blackburn, Michael R. Assassi, Shervin Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation |
title | Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation |
title_full | Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation |
title_fullStr | Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation |
title_full_unstemmed | Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation |
title_short | Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation |
title_sort | downregulation of cfim25 amplifies dermal fibrosis through alternative polyadenylation |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041714/ https://www.ncbi.nlm.nih.gov/pubmed/31757866 http://dx.doi.org/10.1084/jem.20181384 |
work_keys_str_mv | AT wengtingting downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation AT huangjingjing downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation AT wagnerericj downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation AT kojunsuk downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation AT wuminghua downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation AT wareingnancye downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation AT xiangyu downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation AT chenningyuan downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation AT jiping downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation AT molinajoseg downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation AT volcikkellya downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation AT hanleng downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation AT mayesmaureend downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation AT blackburnmichaelr downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation AT assassishervin downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation |